Evidence map›Paper›PMID 32319236›Full record

ArticleJournal of clinical neurology (Seoul, Korea)2020

[¹⁸F]THK5351 PET Imaging in Patients with Mild Cognitive Impairment.

Hye Jin Jeong, Hyon Lee, Sang Yoon Lee, Seongho Seo, Kee Hyung Park, Yeong Bae Lee, Dong Jin Shin, Jae Myeong Kang, Byeong Kil Yeon, Seung Gul Kang and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical neurology (Seoul, Korea), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. New Research on Biomarkers in Alzheimer's Continuum.Reviews on recent clinical trials · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. [Journal of clinical neurology (Seoul, Korea) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Longitudinal Assessment of Tau-Associated Pathology byDiagnostics (Basel, Switzerland) · 2021
    Article
  12. Alzheimer disease.Nature reviews. Disease primers · 2021
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Hye Jin Jeong *Neuroscience Research Institute, Gachon University, Incheon, Korea.ORCID https://orcid.org/0000-0003-3765-8546
Hyon Lee *Department of Neurology, Gachon University Gil Medical Center, Incheon, Korea.ORCID https://orcid.org/0000-0002-0273-8960
Sang Yoon LeeDepartment of Neuroscience, College of Medicine, Gachon University, Incheon, Korea.ORCID https://orcid.org/0000-0002-6029-8553
Seongho SeoDepartment of Neuroscience, College of Medicine, Gachon University, Incheon, Korea.ORCID https://orcid.org/0000-0001-7894-0535
Kee Hyung ParkDepartment of Neurology, Gachon University Gil Medical Center, Incheon, Korea.ORCID https://orcid.org/0000-0001-6847-6679
Yeong Bae LeeDepartment of Neurology, Gachon University Gil Medical Center, Incheon, Korea.ORCID https://orcid.org/0000-0001-5952-1423
Dong Jin ShinDepartment of Neurology, Gachon University Gil Medical Center, Incheon, Korea.ORCID https://orcid.org/0000-0002-4390-2843
Jae Myeong KangDepartment of Psychiatry, Gachon University Gil Medical Center, Incheon, Korea.ORCID https://orcid.org/0000-0003-0803-9332
Byeong Kil YeonDepartment of Psychiatry, Gachon University Gil Medical Center, Incheon, Korea.ORCID https://orcid.org/0000-0002-4853-3178
Seung Gul KangDepartment of Psychiatry, Gachon University Gil Medical Center, Incheon, Korea.ORCID https://orcid.org/0000-0003-4933-0433
Jaelim ChoDepartment of Occupational and Environmental Medicine, Gachon University Gil Medical Center, Incheon, Korea.ORCID https://orcid.org/0000-0002-4524-0310
Joon Kyung SeongDepartment of Biomedical Engineering, Korea University, Seoul, Korea.ORCID https://orcid.org/0000-0001-6291-5415
Nobuyuki OkamuraTohoku Medical and Pharmaceutical University, Sendai, Japan.ORCID https://orcid.org/0000-0002-5991-7812
Victor L VillemagneDepartment of Molecular Imaging & Therapy, Centre for PET, Austin Health, Melbourne, VIC, Australia.ORCID https://orcid.org/0000-0002-5832-9875
Duk L NaDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-1572-7862
Young NohDepartment of Neurology, Gachon University Gil Medical Center, Incheon, Korea.ORCID https://orcid.org/0000-0002-9633-3314
Gachon University Gil Medical Center · KRGachon University · KRKorea University · KRSamsung Medical Center · KRThe University of Melbourne · AUTohoku Medical and Pharmaceutical University · JP

Funding

Korea Health Industry Development Institute HI14C1135National Research Foundation of Korea 2018M3C7A1056889
6 · The paper itself

Abstract

background and purposeMild cognitive impairment (MCI) is a condition with diverse clinical outcomes and subgroups. Here we investigated the topographic distribution of tau in vivo using the positron emission tomography (PET) tracer [¹⁸F]THK5351 in MCI subgroups.

methodsThis study included 96 participants comprising 38 with amnestic MCI (aMCI), 21 with nonamnestic MCI (naMCI), and 37 with normal cognition (NC) who underwent 3.0-T MRI, [¹⁸F]THK5351 PET, and detailed neuropsychological tests. [¹⁸F]flutemetamol PET was also performed in 62 participants. The aMCI patients were further divided into three groups: 1) verbal-aMCI, only verbal memory impairment; 2) visual-aMCI, only visual memory impairment; and 3) both-aMCI, both visual and verbal memory impairment. Voxel-wise statistical analysis and region-of-interest -based analyses were performed to evaluate the retention of [¹⁸F]THK5351 in the MCI subgroups. Subgroup analysis of amyloid-positive and -negative MCI patients was also performed. Correlations between [¹⁸F]THK5351 retention and different neuropsychological tests were evaluated using statistical parametric mapping analyses.

results[¹⁸F]THK5351 retention in the lateral temporal, mesial temporal, parietal, frontal, posterior cingulate cortices and precuneus was significantly greater in aMCI patients than in NC subjects, whereas it did not differ significantly between naMCI and NC participants. [¹⁸F] THK5351 retention was greater in the both-aMCI group than in the verbal-aMCI and visualaMCI groups, and greater in amyloid-positive than amyloid-negative MCI patients. The cognitive function scores were significantly correlated with cortical [¹⁸F]THK5351 retention.

conclusions[¹⁸F]THK5351 PET might be useful for identifying distinct topographic patterns of [¹⁸F]THK5351 retention in subgroups of MCI patients who are at greater risk of the progression to Alzheimer's dementia.

Indexed as

mild cognitive impairmentneurofibrillary tanglespositron emission tomography

Identifiers

PMID32319236
PMCPMC7174126
OpenAlexW3015782501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.